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SUMMARY.-At low concentrations of DMBA (1% and 1%) twice as many
sarcomas and carcinomas of the salivary glands are induced in male as in
female rats. Additional oestrogens reduce neoplasms in males by one half
while testosterone doubles them in females. The sex difference disappears at
the higher dose levels of the carcinogen (2%).
Females are more sensitive than males to the toxic effects ofDMBA, though
less sensitive to the carcinogenic action.
Carcinomas rise to a single peak within 240 days while sarcomas appear
as late as770days withsecondary andtertiarypeaks. This difference inpattern
of induction may be due to the formation of a fibrous capsule separating
persisting DMBA-deposits from the epithelial structures and thus protecting
them from carcinogenic risk.
THE induction of malignant neoplasms in the salivary glands of rats varies
with sex and can be modifiedby castration andby administration of sex hormones
(Glucksmann and Cherry, 1966). For the same dose of the carcinogen tumour
incidence isgreater in males than infemales, and is reduced in malesbyoestrogens
and increased in females by testosterones. At this dose level sarcomas and car-
cinomas are elicited inequalproportions inmales, while in females twice as many
sarcomas as carcinomas are induced. The present investigation is concerned
with the effect ofvarying the carcinogenic dosage on the sex difference in tumour
induction and the proportion ofresulting sarcomas and carcinomas.
Experiments on careinogenesis in the cervico-vaginal tract of rats have shown
that the incidence of sarcomas increases with increasing numbers of weekly
applications ofthecarcinogen, but there is anoptimal level ofdosage for the induc-
tion of epithelial tumours and subsequent inhibition of tumour formation
(Glucksmann and Cherry, 1970a and b). If salivary gland tumours behave
similarly, doubling the concentration of the carcinogen might be expected to
increase the incidence of sarcomas but to reduce that ofcarcinomas, whilehalving the concentration might increase the induction of carcinomas both relatively to
sarcomas and absolutely. Dose variation may also affect the sex difference and
account for some contradictory findings by different authors. Thus Steiner
(1942) and Bauer and Byrne (1950) have not found an influence of sex on car-
cinogenesis, while Heiman and Meisel (1946), Reuber (1960) and Glucksmann and
Cherry (1966) have reported it.
Ourinvestigation shows that the incidence of sarcomas as well as ofcarcinomas
increases with dose of carcinogen and that the sex difference disappears with the
highest dose ofcarcinogen used.213 INDUCTION OF RAT SALIVARY GLAND NEOPLASMS
MATERIALS AND METHODS
Two to three months old male and female hooded rats of the Lister strain,
random bred in this laboratory as a closed colony since 1940, were used for the
experiments. The rats were housed not more than seven to a cage and given
water and food pellets ofMRC-diet 86 ad libitum.
The carcinogen 9,10-dimethyl-1,2-benzanthracene (DMBA, Light & Co. or
Sigma) was dissolved in acetone and the concentration was varied to give a %
or a I % solution or a 2% suspension. Each rat received under ether anaesthesia
aninjection of0-I ml. of one ofthecarcinogenic solutions into theright and the left
salivary gland complex, in a few experiments after and in most without surgical
exposure of the salivary glands. For each complex 045 ml. was injected in an
anterior direction to deposit the carcinogen in the submandibular and closely
applied sublingual glands and the other 0-05 ml. was directed posteriorly into the
parotid gland. Control animals received a similar quantity of acetone by the
same injection technique.
In one group of females a 30 mg. pellet ofpure testosterone propionate (Ciba)
wasimplantedsubcutaneously at the same time as theinjection of 1 % DMBA was
administered. Stilboestrol B.P. was given to one group of males in the drinking
water in a concentration of 0-1 mg./1000 ml. thus dosing each rat with about
2 #g. per day. This treatment was started one day after the injection of 1 %
DMBA.
TABLEI.-Treatment Groups, Sex and Number ofRats at Risk
Injection into salivary Number
glands of Sex at risk
Acetone. 7
Acetone. 7
1% DMBA in acetone 22
J% DMBA in acetone 19
1% DMBA in acetone 40
1% DMBA in acetone 25
1% DMBA in acetone* CT 19
1% DMBA in acetonet 9 16
2% DMBA in acetone 18
2% DMBA in acetone 10
This group received additional treatment with stilboestrol.
t This group received additional treatment with testosterone.
The rats were examined at weekly intervals, swelling or ulceration in the
neck noted and, apart from those in which severe, protracted ulceration necessi-
tated early killing, the animals were allowed to survive until clinical signs of
tumours in the neck appeared. Only those surviving for more than 60 days
were considered at risk. The details of treatment, sex and number of animals
in the various experimental groups are given in Table I. Each group consisted
initially of 21 to 44 rats.
At autopsy the right and left salivary gland complexes were dissected off the
tumours where possible and fixed separately in Bouin's fluid, dehydrated and
embedded in paraffin. The blocks were cut seriaRy and every fifth section taken.
The tumours were fixed in Zenker-acetic as were the foRowing additional tissues:
pituitary, thy-roid, thymus, lungs, liver, spleen, kidneys, adrenals, gonads with
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was processed in routine manner, embedded in paraffin and sectioned at 6 or 8 It
depending on organ; the endocrine glands were sectioned serially.
Sections were stained with haematoxylin-eosin, the periodic acid-Schiff
technique (PAS) after diastase digestion, Southgate's mucicarmine, Trevan's
alcian blue-basic fuchsin method, Van Gieson or with carmalum-orange G-aniline
blue.
Calculation of results
For the age-specific induction rates the number of tumour-bearing animals
amongst those at risk for consecutive 30-day periods was plotted at the 15-day
interval.
RESULTS
Early ulceration in relation to dosage of DMBA and sex
Injection of DMBA in acetone is followed rapidly by a swelling in the neck
which enlarges at varying rates. In some rats this expansion leads to breakage
of the overlying skin during the second week resulting in a primary ulceration
which may be of such severity and persistence as to necessitate the killing of the
animals. In others the ulceration is slight, heals by the 40th day or is entirely
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Fic.. l.-Percentage of male (d) and female (y) rats killed because of severe persistent ulceration
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absent. Thelump inthe neckregionenlarges andbecomesharder andifcomposed
ofmalignant tissue may cause a secondary ulceration. In rats which fail to pro-
duce tumours, the original swelling is resorbed and the only macroscopic change
consists of some fibrosis oftheglandular capsules.
In rats injected with acetone only, an initial swelling in the neck regioil is
quickly reduced and resorbed and the injected region appears entirely normal
after about 3 weeks. In other experiments olive oil used as solvent produces
little swelling, but leaves behind a granulomatous reaction. Neither acetone
nor olive oil injected controls have ever produced any lumps leading to early
ulceration. Those given DMBA (I %) in olive oil (Cherry and Glucksmann, 1965)
produce swellings and tumours, but have not suffered from early ulceration,
though secondary ulcers due to malignancy have occurred.
Early ulceration following injection of DMBA in acetone varies in incidence
and severity with concentration of the DMBA and sex of the rats (Fig. 1). No
early ulceration follows after treatment with % DMBA in either males or females.
After I % DMBA, 7 % of 44 males and 15% of 32 females have been killed within
40 days because of severe and persisting ulcers in the neck. At 2% DMBA
severe ulceration has occurred in 24% of 25 males and 48% of 23 females. The
difference is notquitesignificant at the 95% confidence level. There is,however, a
significant difference between the sexes if rats treated at the I % and 2% level
are considered: 13 + 4% of 69 males are afflicted as against 29 ± 6-1 % of
55 females (Diff: 16 ± 7-3). As the graph shows, the incidence of early ulcers
increases rapidly with concentration ofthe carcinogen.
At the 2% level a mild and transient ulceration has been seen in 6 of 18 males
and 5 of 10 females. It has startedby the 15th day and healedby 40 days in all
except 2 males in whom the ulceration has been delayed to about 40 days and the
healing to between 68 and 90 days. All II animals with ulcers have tumours
subsequently and only 2 of 17 are without ulceration and tumours (Table 11).
TABLEII.-Tumour Incidence in Rats Injected with 2% DMBA in Relation
to Transient Early Ulceration
Carcinoma
Sex Ulceration No. Carcinoma + sarcoma Sarcoma No tumour
+ 6 2 3 I 0
12 1 9 0 2
18 3 12 I 2
+ 5 0 2 3 0
5 0 5 0 0
10 0 7 3 0
There is no convincing correlation between type of tumour developing later and
early transient ulceration. Most animals have both sarcomas and carcinomas, though three females with ulcers have sarcomas only. In males with prior ulceration there are two with carcinomas only and one with a sarcoma only. These minor differences are more likely to be accounted forby the sex differences
in the incidence of tumour types than by the preceding ulceration. At the %
level there is noulceration, but carcinomasdevelop in malesthough not in females.216 A. GLUCKSMANN AND CORA P. CHERRY
Histogenesis
An account ofthe histogenesis oftumours in comparison with theregenerative
processes following the injection of acetone has been given in a previous paper
(Cherry and Glucksmann, 1965). Since that time some additional features have
come tolight and are dealt with here. The lethal and sublethal effects of acetone
do not prevent rapid removal of dead tissue by immigrating phagocytes, fibro-
plasia by the influx of fibroblasts and squamous metaplasia of dedifferentiated
acini and ducts followedbysprouting of new ducts which isprobably aidedby the
presence ofthe connective tissue. Oedema and vasculardamage are also quickly
repaired and after 3 weeks the glands appear normal.
DMBA is toxic and this effect is superimposed on the lethal and sublethal
actions of the solvent. It is also slowly resorbed and necrotic tissue and some
crystal deposits are present as late as 1,50 days after injection. Whether and in
what way the chemical structure of the DMBA is altered during this period, is
not known. It seems to be still active since sarcomas arise after this period of
time. DMBA is more toxic to the inflammatory cells, macrophages and fibro-
blasts than to the epithelial components. Thus the necrotic tissue with the
DMBAdeposits are firsteneystedbyepithelial tissuemigrating from theremaining
dedifferentiated glandular structures. Epithelial tumours tend to develop from
thislining which at first is surroundedby oedematous tissue withonly few inflam-
matory and connective tissue cells. Later new immigrating cells encompass the
often incomplete cysts and in time may give rise to sarcomas, which in tum may
cut off the blood supply for the carcinomatous cysts and thus strangulate the
epithelial neoplasms.
In the previous study only squamous celled carcinomas have been obtained.
In the present experiments 8 of the 63 epithelial tumours are mixed carcinomas,
i.e. contain a secretory columnar as well as a keratinising squamous cell strain.
There is a suggestion of a sex linked difference in the incidence ofthese tumours:
they are present in 7 of 48 carcinomas in males, butonly once in 15 carcinomas in
females. In alarger series of cases, however, no evidence for a sex linked appear-
ance of tumour types is obtained. In a series of 300 carcinomas of the salivary
glands 18% are of the mixed type and the rest merely squamous celled tumours.
In rats additionally treated with various hormones the proportion of mixed to
squamous celled carcinomas does not differsignificantly in males, females, castrate
males and castrate females.
The sarcomas are ofdifferentgrades ofmaturityvarying from cellulartypes to
fairly differentiated tumours such as rhabdomyofibrosarcomas. Of 529 sarcomas
induced in 684 rats 60% are rhabdomyofibrosarcomas, 34% fibrosarcomas, 3%
myxofibrosarcomas and 3 %haemangiofibrosarcomas. The incidence ofthe differ-
enttypes does not varysignificantlywith sex ofthe animals and castration. There
are, however, significant differences in the incidence ofcarcinomas and of sarcomas
with sex and these are dependent on the dose ofcarcinogeninjected.
Incidence of carcinomas
In rats of both sexes carcinomas arise between 60 (exceptionally 40) and
240days (Fig. 2 and3) with apeak incidence at around 100days (Fig. 3). Signifi- cantly more carcinomas occur over alongerperiod oftime in males than in females
(61 % ± 5-5 and 28% ± 6-1 respectively). The sex difference in incidence of-- I-
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FIG. 2.-Cumulative percentage of carcinomas induced in male and female rats by the
administration of 1, 1 and 2% of DMBA and at 1% DMBA in males given additionany
oestrogens and females given testosterone.
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FIG. 3.-Age-specific rates of induction of carcinomas and sarcomas in males (,S) and females
(?) at consecutive 30-day intervals from the injection of DMBA (I + 1 + 2%).
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carcinomas varies with the dose of carcinogen (Fig. 2), being significant at the
% and I % level and absent at the 2% concentration. In males there is asignifi-
cant increase and shortening ofthe inductionperiod between % and I % DMBA,
but a maximum is reached at I % and no further shortening or addition to per-
centage is gained at 2%. In females significant differences in percentage of
induced epitheliomas and duration of the induction period obtain for the 3 4ose
levels.
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FiG. 4.-Age-specific rates for carcinomas induced by I% DMBA in males and females and in
males given oestrogens and females tes'tosterones.
Carcinoma incidence in females at 2% equals that in males at I %, while at
I % in females it is only slightly and not significantly greater than in males given
The liability to respond with e itheliomas to a given dose of DMBA is
thus roughly twice as great in males than in females. A similar quantitative
relation obtains if males are treated at the 1 % level with oestrogens and females
with testosterones (Fig. 2 and 4). Oestrogen reduces the cancer incidence in
males from the I % to the % level, while testosterone increases the incidence in
females from the I % to the 2% level. The factor of 2 in the sex difference for
carcinomas thus appears to be attributable to the action ofthegonadal hormones.
Incidence of sarcomas
While carcinomas reach a single peak at about 100 days and subsequently
decline to nil by 240 days, sarcomas have an early peak also at 100 days, but
subsequently decline only slowly, with some secondary and even tertiary peaks
and do not cease to appear before 390 days (Fig. 5). In some experiments new
sarcomas are formed as late as 770 days (Fig. 6). The difference in the pattern
ofinduction ofsarcomasandcarcinomasmayreflectthehistogenesisofthetumours:INDUCTION OF RAT SALIVARY GLAND NEOPLASMS 219
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epitheliomas arise in resident tissueincluding the outgrowth from dedifferentiated
adjacentglandular structures, while sarcomas arise in the cellsbrought in with the
vessels, i.e. animmigrantpopulation which comes under the influence ofpersisting
DMBA crystals. The early eneystation by epithelial formations gives place to
encapsulationby fibroblasts and fibres which form a barrier between thepersisting
DMBA and the epithelium. Both these factors would account for the limita-tion
in time of the risk of carcinoma induction and for the extension in liability to
sarcomas.
The difference in the pattern of epithelial and mesenchymatous neoplasms
is also reflected in a sex difference (Fig. 3). In males the early peak of sarcomas,
like that for carcinomas, ishigher than in females and subsidiarypeaks tend to be
higher, but not of such long duration. While in males only 3% ± 1-8 of all
sarcomas occur after 240 days, in females a significantlv greater percentage do so,
i.e. 17% ± 6-3.
As with carcinomas the sex differences in the incidence of sarcomas vary with
dosage of DMBA. At I % the sarcomas in males (91 % ± 6
-1) are significantly
more numerous and develop faster than in females (47% ± 11-5); at I % the
total incidence of sarcomas is the same, but they arise more slowly in females;
at 2% there is no difference in incidence nor in duration of the inductionperio.- There is again a factor ofabout 2 in thesensitivity to sarcomas between the sexes:
at % about one half as many tumours are formed in females as in males, and at
infemales as manyneoplasms are induced as at % in males (Fig. 6). Testo-
sterone treatment of females at I % DMBA enhances tumour formation to the
0%
80-
40-
0-
i
300 6 0
Days
Fia. 7.-Age-specific rates for sarcomas induced by 1% DMBA in males and femajes and in
males given oestrogens and females testosterones.221 INDUCTION OF RAT SALIVARY GLAND NEOPLASMS
2%level, while males at I %DMBAgiven estrogensproduceonly asmany tumours
as females injected with 1 Y,, DMBA. An age specific plot of tumour incidence
at 1 % DMBA (Fig. 7) shows a striking difference between the sexes with a single
peak and short duration in males and a plateau-like pattern extending for a long
period in females. The administration oftestosterone changes the female pattern
to W' male one and that of oestrogen into males converts the male pattern to a
female one with a great extension of the induction period.
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FiG. 8.-Dose-response curve for carcinomas and sarcomas in male and femaje rats injected with vaxious concentrations of DMBA.
In males as many sarcomas are induced by I% as by I or 2%, but more
slowly. As with carcinomas there is no difference in the treatments with I % and 2%. In females the incidence and speed of sarcoma induction increases with
dose from the I% to the 2% level. The sex and dosage differences in induction
rates of sarcomas and carcinomas are illustrated in Fig. 8. In females sarcomas
as well as carcinomas increase with dose and there are always more sarcomas
induced than carcinomas. There is strict parallelity in the augmentation with
dose of the two tumour types. In males the total incidence of sarcomas is not
significantly alteredbyvariationsinDMBAdosage, while carcinomas increaseonly between I% and I % DMBA. At I % and 2% as many sarcomas as carcinomas
appear, and only at I % are there niore sarcomas than carcinomas.222 A. GLUCKSMANN AND CORA P. CHERRY
DISCUSSION
For the induction of carcinomas and sarcomas the sex difference is marked at
low levels ofcarcinogenic dosage, but disappears at high doses of DMBA (Fig. 8).
The difference is thus quantitative rather than qualitative and there is a spectrum
of individual sensitivity between males and females with a considerable degree of
overlap. Some females respond as fast as males to the same dose of DMBA.
The statistical difference between the sexes at lower dose levels is confirmed by
such hormonal effects as the reduced tumour induction in males given oestrogens
and the increased induction in females given testosterone at equivalent doses of
carcinogens. There is a factor of about 2 between the sexes for induction of
neoplasms at the 1 % and I % level of DMBA. At the I % level of DMBA in
males given oestrogen and females given testosterone the hormonal effect is
equivalent to a factor of 2 in carcinogenic dosage.
The sex difference in sensitivity to carcinogens of the salivary glands is not
relatedmorphologically to the sexualdimorphism in the structure ofthe secretory
tubules of the submandibular gland. Hardly any carcinomas and no sarcomas
arise in these formations. It is feasible, however, that the secretory tubules in
males produce substances which promote the growth ofepithelial and connectiye
tissues in theglandularcomplex similar to the factors secreted there whichpromote
the growth of nerves and the epidermis (Levi-Montalcini, 1965; Cohen, 1965).
Such factorsmight also influence thegrowth ofepithelial and sarcomatous tumours
and would act in addition to the growth promotion by carcinogens at low doses,
though their contribution athigh doses ofthe carcinogen might becomenegligible. The carcinogenic effect of DMBA does not appear to be closely related to the
toxic action of the compound, though the latter is also sex-linked with females
producing twice as many severe early persistent ulcers as males given the same
dose (Fig. 1). At % DMBA there is no ulceration in either males or females
but ahighlysignificant difference between the sexes in the incidence ofcarcinomas
and sarcomas (Fig. I and 8). Conversely at 2% DMBA ulceration differs signifi- cantly between the sexes, but not the percentage of induced tumours (Fig. I and
8). The sensitivity to the carcinogenic like that to the toxic action of DMBA
varies between the sexes by a factor of2, but in opposite direction: males respond
more to the carcinogenic, but less to the toxic effect ofDMBA than females. The
transient early ulceration elicited by treatment with 2% DMBA (Table 11) though sex-linked does not appear to influence subsequent tumour formation
supporting the conclusion that the carcinogenic effect of DMBA is independent of
the toxic 4action.
The severe persistent ulceration induced by bigger doses of DMBA restricts
the range of concentrations which can be explored for careinogenesis. At this
site unlike the cervico-vaginal tract, tumour formation increases with dose to a
maximum which is reached at 1 % in males andequalledby 2% in females. There
is thus no evidence for an optimal dosephenomenon as described for the incidence
ofepithelial tumours of the cervico-vaginal tract (Glucksmann and Cherry, 1970a
and b).
In both sexes the threshold carcinogenic dose is lower for sarcomas than car-
cinomas (Fig. 8); more sarcomas than carcinomas are induced by the samedose
of DMBA up to a maximal level for both which is higher for sarcomas (up to
100%) than for carcinomas (up to 80%) in the present series of experimentsINI)UCTION OF RAT SALIVARY GLAND NEOPLASMS 223
(Fig. 8) as well as in other experiments performed on castrate animals and with
various hormonal administrations; carcinomas do not appear after 240 days
(Fig. 2) while sarcomas may appear as late as 770 days (Fig. 6); the percentage of
epithelial neoplasms induced risesto a single peak, while with the exception ofmales
given 1 % DMBA, sarcomas have two or more peak incidences (Fig. 3, 5, 7).
Sarcomas are thus induced with smaller doses, in greater number and for a longer
time than carcinomas. The histogenesis of these types of tumours may provide
an explanation for these differences.
Apart from the immediate death of tissue caused by acetone as solvent for
the hydrocarbon, there is a progressive necrosis due to the DMBA deposits
acting for prolonged periods which enlarges the lesion. Though with distance the
toxic effect of DMBA is diluted, it still prevents the conspicuous fibroblastic
reaction following the acute killing by acetone and causes the death ofimmigrating
inflammatory cells. The necrotic tissue is at first incompletely encysted by epithe-
lium growing from the remaining viable glandular structures and this lining pro-
tects to some extent immigrating fibroblasts and other mesenchymatousformations
which attempt to encapsulate the encysted necrotic tissue with its content of
DMBA. Necrosis of such mesenclhymatous elements spreads the lesion and
involves adjacent muscles. connective tissueand blood vessels. Carcinomas arisein
the lining of the cysts and sarcomas in the stroma of the carcinomas and in the
encapsulating mesenchymatous structures which prevent further direct contact
between the DMBA deposits and epithelial formationis. Thus only the original en-
cysting epithelium is exposed to carcinogenic risk, while with the expansion of the
lesion through progressive necrosis new cellular populations in connective tissue,
muscles, blood vessels and perivascular regions are brought under the influence of
the more dilute remains of DMBA. Thus the mesenchymatous elemnents have
a greater and more prolonged opportunity to react to the carcinogen than the epi-
thelium. There is no need to postulate a differential sensitivity for these elements
to carcinogens and indeed the initial peaks of carcinomas and sarcomas are of the
samne height (Fig. 3 and 5), while the subsequent peaks in incidence of sarcomas
(Fig. 3, 5 and 7) reflect the prolonged exposure to risk. The fact that peaks occur
at intervals instead of a plateau or steadily diminishing incidence, suggests that
new populationis of mesenchymatous cells are involved in tumour production.
The sex differeince in the reaction of connective tissues and epithelium appears
to be mediated by the sex hormones (Fig. 4 and 7) which enhance or reduce the
sensitivity to carcinogenic action by a factor of 2 and thus equal the sex difference
at the lower levels of carcinogenic dosage. Changes in sensitivity or reactivity
rather than in adaptability to the effects of DMBA are involved, since persistent
as well as transient ulcerations occur more frequently in females than in males,
while more neoplasms arise in males than in females. A greater adaptability,
i.e. ability to cope and recoverfroma the noxious effects ofDMBA shouldbereflected
in parallel fashion in ulceration and tumour formation, while in fact these two
processes appear to be quite distinct from one another.
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